http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20150014308-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L2-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-401 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P21-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-401 |
| filingDate | 2013-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2015-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20150014308-A |
| titleOfInvention | Pharmaceutical composition for preventing or treating muscle weakness diseases comprising Protirelin |
| abstract | The present invention relates to a composition for promoting the differentiation of myoblast comprising protirelin or a pharmaceutically acceptable salt thereof, comprising treating the extracorporeal cells with protyrelin or a pharmaceutically acceptable salt thereof A method for promoting differentiation of myocardial cells, a method for producing differentiated myocytes comprising the step of differentiating a source cell by treating protoorrene or a pharmaceutically acceptable salt thereof with an extracorporeal myoblast, a method for producing prolylene or a pharmaceutically acceptable salt thereof A pharmaceutical composition for preventing or treating muscular weakness related to muscle weakness including an acceptable salt, a food composition for preventing or ameliorating muscle weakness-related diseases, and a composition for strengthening muscle strength. The prothyrelin according to the present invention can promote the differentiation of myoblasts to form a root canal, thereby preventing muscle weakness and effectively improving muscle function. Accordingly, the pharmaceutical composition containing the same can be usefully used for the prevention or treatment of muscular weakening-related diseases. |
| priorityDate | 2013-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 276.